Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Structure of C3b reveals conformational changes that underlie complement activity

Nature volume 444, pages 213–216 (2006)Cite this article

Abstract

Resistance to infection and clearance of cell debris in mammals depend on the activation of the complement system, which is an important component of innate and adaptive immunity1,2. Central to the complement system is the activated form of C3, called C3b, which attaches covalently to target surfaces3 to amplify complement response, label cells for phagocytosis and stimulate the adaptive immune response. C3b consists of 1,560 amino-acid residues and has 12 domains. It binds various proteins and receptors to effect its functions4. However, it is not known how C3 changes its conformation into C3b and thereby exposes its many binding sites. Here we present the crystal structure at 4-Å resolution of the activated complement protein C3b and describe the conformational rearrangements of the 12 domains that take place upon proteolytic activation. In the activated form the thioester is fully exposed for covalent attachment to target surfaces and is more than 85 Å away from the buried site in native C3 (ref. 5). Marked domain rearrangements in the α-chain present an altered molecular surface, exposing hidden and cryptic sites that are consistent with known putative binding sites of factor B and several complement regulators. The structural data indicate that the large conformational changes in the proteolytic activation and regulation of C3 take place mainly in the first conversion step, from C3 to C3b. These insights are important for the development of strategies to treat immune disorders that involve complement-mediated inflammation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Structure of C3b at 4-Å resolution.
Figure 2: Thioester exposure for covalent target attachment.
Figure 3: Exposure and generation of cryptic binding sites.
Figure 4: Proposed model for the conformational pathway of C3.

Similar content being viewed by others

References

  1. Walport, M. J. Complement. First of two parts. N. Engl. J. Med. 344, 1058–1066 (2001)

    Article  CAS  PubMed  Google Scholar 

  2. Carroll, M. C. The complement system in regulation of adaptive immunity. Nature Immunol. 5, 981–986 (2004)

    Article  CAS  Google Scholar 

  3. Law, S. K. & Levine, R. P. Interaction between the third complement protein and cell surface macromolecules. Proc. Natl Acad. Sci. USA 74, 2701–2705 (1977)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  4. Lambris, J. D. The multifunctional role of C3, the third component of complement. Immunol. Today 9, 387–393 (1988)

    Article  CAS  PubMed  Google Scholar 

  5. Janssen, B. J. et al. Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 437, 505–511 (2005)

    Article  ADS  CAS  PubMed  Google Scholar 

  6. Mastellos, D. & Lambris, J. D. Complement: more than a ‘guard’ against invading pathogens?. Trends Immunol. 23, 485–491 (2002)

    Article  CAS  PubMed  Google Scholar 

  7. Tack, B. F., Harrison, R. A., Janatova, J., Thomas, M. L. & Prahl, J. W. Evidence for presence of an internal thiolester bond in third component of human complement. Proc. Natl Acad. Sci. USA 77, 5764–5768 (1980)

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  8. Fishelson, Z., Pangburn, M. K. & Muller-Eberhard, H. J. Characterization of the initial C3 convertase of the alternative pathway of human complement. J. Immunol. 132, 1430–1434 (1984)

    CAS  PubMed  Google Scholar 

  9. Helmy, K. Y. et al. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 124, 915–927 (2006)

    Article  CAS  PubMed  Google Scholar 

  10. Dempsey, P. W., Allison, M. E., Akkaraju, S., Goodnow, C. C. & Fearon, D. T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271, 348–350 (1996)

    Article  ADS  CAS  PubMed  Google Scholar 

  11. Ross, G. D., Lambris, J. D., Cain, J. A. & Newman, S. L. Generation of three different fragments of bound C3 with purified factor I or serum. I. Requirements for factor H vs CR1 cofactor activity. J. Immunol. 129, 2051–2060 (1982)

    CAS  PubMed  Google Scholar 

  12. Harrison, R. A. & Lachmann, P. J. Novel cleavage products of the third component of human complement. Mol. Immunol. 17, 219–228 (1980)

    Article  CAS  PubMed  Google Scholar 

  13. Nagar, B., Jones, R. G., Diefenbach, R. J., Isenman, D. E. & Rini, J. M. X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2. Science 280, 1277–1281 (1998)

    Article  ADS  CAS  PubMed  Google Scholar 

  14. Brown, K. M. et al. Influence of donor C3 allotype on late renal-transplantation outcome. N. Engl. J. Med. 354, 2014–2023 (2006)

    Article  CAS  PubMed  Google Scholar 

  15. Dodds, A. W., Ren, X. D., Willis, A. C. & Law, S. K. The reaction mechanism of the internal thioester in the human complement component C4. Nature 379, 177–179 (1996)

    Article  ADS  CAS  PubMed  Google Scholar 

  16. Pangburn, M. K., Schreiber, R. D. & Muller-Eberhard, H. J. C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface. J. Immunol. 131, 1930–1935 (1983)

    CAS  PubMed  Google Scholar 

  17. Sim, R. B., Twose, T. M., Paterson, D. S. & Sim, E. The covalent-binding reaction of complement component C3. Biochem. J. 193, 115–127 (1981)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Taniguchi-Sidle, A. & Isenman, D. E. Interactions of human complement component C3 with factor B and with complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) involve an acidic sequence at the N-terminus of C3 alpha′-chain. J. Immunol. 153, 5285–5302 (1994)

    CAS  PubMed  Google Scholar 

  19. O′Keefe, M. C., Caporale, L. H. & Vogel, C. W. A novel cleavage product of human complement component C3 with structural and functional properties of cobra venom factor. J. Biol. Chem. 263, 12690–12697 (1988)

    PubMed  Google Scholar 

  20. Kolln, J., Spillner, E., Andra, J., Klensang, K. & Bredehorst, R. Complement inactivation by recombinant human C3 derivatives. J. Immunol. 173, 5540–5545 (2004)

    Article  PubMed  Google Scholar 

  21. Inal, J. M. & Schifferli, J. A. Complement C2 receptor inhibitor trispanning and the beta-chain of C4 share a binding site for complement C2. J. Immunol. 168, 5213–5221 (2002)

    Article  CAS  PubMed  Google Scholar 

  22. Daoudaki, M. E., Becherer, J. D. & Lambris, J. D. A 34-amino acid peptide of the third component of complement mediates properdin binding. J. Immunol. 140, 1577–1580 (1988)

    CAS  PubMed  Google Scholar 

  23. Oran, A. E. & Isenman, D. E. Identification of residues within the 727–767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35). J. Biol. Chem. 274, 5120–5130 (1999)

    Article  CAS  PubMed  Google Scholar 

  24. Lambris, J. D., Avila, D., Becherer, J. D. & Muller-Eberhard, H. J. A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides. J. Biol. Chem. 263, 12147–12150 (1988)

    CAS  PubMed  Google Scholar 

  25. Clemenza, L. & Isenman, D. E. Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21). J. Immunol. 165, 3839–3848 (2000)

    Article  CAS  PubMed  Google Scholar 

  26. Lambris, J. D., Dobson, N. J. & Ross, G. D. Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulin. J. Exp. Med. 152, 1625–1644 (1980)

    Article  CAS  PubMed  Google Scholar 

  27. The C. C. P. 4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50, 760–763 (1994)

  28. Storoni, L. C., McCoy, A. J. & Read, R. J. Likelihood-enhanced fast rotation functions. Acta Crystallogr. D Biol. Crystallogr. 60, 432–438 (2004)

    Article  PubMed  Google Scholar 

  29. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 (2004)

    Article  PubMed  Google Scholar 

  30. Nicholls, A., Bharadwaj, R. & Honig, B. GRASP: Graphical representation and analysis of surface properties. Biophys. J. 64, 166–170 (1993)

    Google Scholar 

Download references

Acknowledgements

We acknowledge the European Synchrotron Radiation Facility for provision of synchrotron radiation facilities; and S.J. Kolodziej and J.K. Stoops (Houston) for providing the native α2-macroglobulin and methylamine-treated α2-macroglobulin EM-reconstruction maps. We thank B. Nilsson (Uppsala), R.B.G. Ravelli (Grenoble) and E.G. Huizinga (Utrecht) for reading the manuscript. This work was supported by a ‘Pioneer’ programme grant to P.G. by the Council for Chemical Sciences of the Netherlands Organization for Scientific Research (NWO-CW) and an NIH grant to J.D.L.

Author information

Authors and Affiliations

  1. Crystal and Structural Chemistry, Bijvoet Center for Biomolecular Research, Faculty of Sciences, Utrecht University, Padualaan 8, 3584 CH, Utrecht, The Netherlands

    Bert J. C. Janssen & Piet Gros

  2. Department of Pathology and Laboratory Medicine, School of Medicine, University of Pennsylvania, Philadelphia, 19104, USA

    Agni Christodoulidou & John D. Lambris

  3. European Molecular Biology Laboratory, Grenoble Outstation, 38042, Grenoble, Cedex 9, France

    Andrew McCarthy

Authors
  1. Bert J. C. Janssen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Agni Christodoulidou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrew McCarthy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John D. Lambris
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Piet Gros
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Piet Gros.

Ethics declarations

Competing interests

Coordinates and structure factors of the C3b structure have been deposited in the Protein Data Bank with accession number 2I07. Reprints and permissions information is available at www.nature.com/reprints. The authors declare no competing financial interests.

Supplementary information

Supplementary Figure

Figure captions for Supplementary Tables 1 and 2, Supplementary Figures 1 to 3 and Supplementary Movie. (DOC 71 kb)

Supplementary Table 1

Diffraction data, refinement statistics and molecular replacement scores for C3b (PDF 28 kb)

Supplementary Table 2

Domain rotation and translation between C3b, C3 and C3c. (PDF 11 kb)

Supplementary Figure 1

Electron density for the individual domains of C3b. (PDF 1581 kb)

Supplementary Figure 2

Proteolytic cleavage sites of factor I mapped on the structure of C3b. (PDF 233 kb)

Supplementary Figure 3

Modeling of native and methylamine α2-macroglobulin based on 25-Å resolution EM reconstruction maps. (PDF 1578 kb)

Supplementary Movie

Conformational transition of C3 into C3b. (AVI 4920 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Janssen, B., Christodoulidou, A., McCarthy, A. et al. Structure of C3b reveals conformational changes that underlie complement activity. Nature 444, 213–216 (2006). https://doi.org/10.1038/nature05172

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature05172

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing